The hypermethylation of CpG 106, which overlaps the promoter and exon 1 of RB, was observed to be methylated in most retinoblastoma tumors, thereby suggesting the implications of hypermethylation of promoter-associated CpGs of tumor suppressors in tumorigenesis [111]. The gene discussed is RB1; the disease is neoplasm.